Development of delivery systems for antisense oligonucleotides

被引：0

作者：

Takakura, Y ^{[1
]}

Mahato, RI ^{[1
]}

Nomura, T ^{[1
]}

Sawai, K ^{[1
]}

Yoshida, M ^{[1
]}

Kanamaru, T ^{[1
]}

Hashida, M ^{[1
]}

机构：

[1] KYOTO UNIV,FAC PHARMACEUT SCI,DEPT DRUG DELIVERY RES,SAKYO KU,KYOTO 60601,JAPAN

来源：

ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY SYSTEMS | 1996年

关键词：

antisense oligonucleotide; drug delivery system; pharmacokinetics; organ perfusion experiment; tissue-isolated tumor preparation;

D O I：

暂无

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

引用

页码：357 / 358

页数：2

共 50 条

[31] Comparison of antisense oligonucleotide drug delivery systems [J].

Weyermann, J ;

Lochmann, D ;

Zimmer, A .

JOURNAL OF CONTROLLED RELEASE, 2004, 100 (03) :411-423

[32] Carbosilane Dendrimers are a Non-Viral Delivery System for Antisense Oligonucleotides: Characterization of Dendriplexes [J].

Pedziwiatr-Werbicka, Elzbieta ;

Shcharbin, Dzmitry ;

Maly, Jan ;

Maly, Marek ;

Zaborski, Marian ;

Gabara, Barbara ;

Ortega, Paula ;

Javier de la Mate, F. ;

Gomez, Rafael ;

Angeles Munoz-Fernandez, Ma ;

Klajnert, Barbara ;

Bryszewska, Maria .

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2012, 8 (01) :57-73

[33] BIODEGRADABLE POLY(L-LACTIC ACID) MATRICES FOR THE SUSTAINED DELIVERY OF ANTISENSE OLIGONUCLEOTIDES [J].

LEWIS, KJ ;

IRWIN, WJ ;

AKHTAR, S .

JOURNAL OF CONTROLLED RELEASE, 1995, 37 (1-2) :173-183

[34] Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides [J].

Dias, N ;

Stein, CA .

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2002, 54 (03) :263-269

[35] Self-Assembled Antibody-Oligonucleotide Conjugates for Targeted Delivery of Complementary Antisense Oligonucleotides [J].

Zhou, Liujuan ;

Bi, Jie ;

Chang, Shenghai ;

Bai, Zhaoshuai ;

Yu, Junqi ;

Wang, Ruru ;

Li, Zhihang ;

Zhang, Xing ;

Chou, James J. ;

Pan, Liqiang .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2025, 64 (03)

[36] Injectable Biodegradable Silica Depot for Controlled Subcutaneous Delivery of Antisense Oligonucleotides with beyond Monthly Administration [J].

Mcgowan, Asmaa ;

Gennemark, Peter ;

Akieh-Pirkanniemi, Marceline ;

Wirman, Linda ;

Davies, Nigel ;

Elebring, Marie ;

Tivesten, Anna ;

Strimfors, Marie ;

Holtta, Mikko ;

Soderberg, Magnus ;

Berntsson, Veronica ;

Balas, Daniela ;

Koskinen, Mika ;

Leino, Lasse ;

Abrahmsen-Alami, Susanna .

MOLECULAR PHARMACEUTICS, 2023, 21 (01) :143-151

[37] Enhanced in vivo delivery of antisense oligonucleotides to restore dystrophin expression in adult mdx mouse muscle [J].

Wells, KE ;

Fletcher, S ;

Mann, CJ ;

Wilton, SD ;

Wells, DJ .

FEBS LETTERS, 2003, 552 (2-3) :145-149

[38] Pharmacokinetic-pharmacodynamic modeling for hepatic delivery and efficacy of antisense oligonucleotides with lipophilic ligands in mice [J].

Watanabe, Ayahisa ;

Katsube, Takayuki .

BIOPHARMACEUTICS & DRUG DISPOSITION, 2021, 42 (04) :178-187

[39] Angiotensinogen antisense oligonucleotides and fluid intake [J].

Sinnayah, P ;

McKinley, MJ ;

Coghlan, JP .

CLINICAL AND EXPERIMENTAL HYPERTENSION, 1997, 19 (5-6) :993-1007

[40] Drug Discovery Perspectives of Antisense Oligonucleotides [J].

Kim, Yeonjoon .

BIOMOLECULES & THERAPEUTICS, 2023, 31 (03) :241-252

← 1 2 3 4 5 →